Cell Talk Technology Transfers for CGT products: Understanding what is needed for success Transferring a cell and gene therapy (CGT) product from development to manufacturing involves a detailed…Cell TherapiesJune 20, 2024
Cell Talk Quality Assurance: The Importance of Robust Investigations Quality Assurance: The Importance of Robust Investigations Quality Assurance (QA) is a broad process that…Cell TherapiesApril 22, 2024
Cell Talk Ensuring Every Batch is a Success: Validation and Qualification Ensuring Every Batch is a Success: Validation and Qualification in Cell and Gene Therapy Manufacturing…Cell TherapiesMarch 10, 2024
Cell Talk Translating research discoveries to commercialised cell and gene therapy products; asking the right questions as an academic. When translating research discoveries in the cell and gene therapy sector, numerous considerations must be…Cell TherapiesNovember 28, 2023
Cell Talk From Concept to Commercialisation: Why the selection of an organisation for a cell and gene therapies can impact your patient outcomes and competitive advantage The development pipeline of cell and gene therapies faces numerous obstacles while striving for the…Cell TherapiesAugust 14, 2023
Cell Talk Translating innovative cell therapies: What is GMP? The cell therapy sector is growing rapidly and within it, cell-based therapies derived from human…Cell TherapiesMay 22, 2023
Cell Talk Why Australia should be your choice for CGT development The development of cell and gene therapy is rapidly growing in our industry with a…Cell TherapiesFebruary 22, 2023